Improving the ED alternatives

MacroChem Corp.'s Topiglan topical alprostadil gel, which last week demonstrated statistically significant results in a Phase IIb erectile dysfunction study, could offer doctors a safer alternative to Pfizer Inc.'s Viagra and a more appealing alternative to Vivus Inc.'s Muse ED product.

The topical gel, which is applied to the head of the penis, produced greater rigidity